A study on investigating the effectiveness and safety of integrated platform service for prevention and management of childhood obesity
Not Applicable
Completed
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0002105
- Lead Sponsor
- Inje University Seoul Paik Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
1. those who are healthy (without systematic or metabolic disease condition)
2. BMI ranging from underweight to obese
3. Android smartphone users
4. written informed consent from parents
Exclusion Criteria
no
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physical activity (intensity and total amount);Count of walking step (step a day)
- Secondary Outcome Measures
Name Time Method Anthropometry (objectively measured Body weight, Height, waist circumference, and Body mass index percentile);of food consumption (vegetables, fruit, beverage, snacks, fast food and instant food) and eating at night using the record on platform database;Psychological variables (Self body perception, sleep quality, etc);Dietary pattern and eating habits;Home environment;Frequency, screen-time of the smartphone
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers are analyzed in KCT0002105 to assess childhood obesity management efficacy?
How does the integrated platform in KCT0002105 compare to standard-of-care lifestyle interventions for pediatric metabolic syndrome?
Which molecular pathways or targets are prioritized in the KCT0002105 obesity prevention platform's design?
What adverse events are associated with digital health tools used in KCT0002105 for childhood obesity management?
Are there combination therapies or digital interventions evaluated alongside KCT0002105's platform for metabolic disease prevention?